American Heart Journal
Volume 156, Issue 1 , Pages 31-36, July 2008

Rationale and design of the Post-MI FREEE trial: A randomized evaluation of first-dollar drug coverage for post–myocardial infarction secondary preventive therapies

  • Niteesh K. Choudhry, MD, PhD

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • Corresponding Author InformationReprint requests: Niteesh K. Choudhry, MD, PhD, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120.
    • ,
  • Troyen Brennan, MD, JD, MPH

      Affiliations

    • Aetna Inc Hartford, CT
    • ,
  • Michele Toscano, MS

      Affiliations

    • Aetna Inc Hartford, CT
    • ,
  • Claire Spettell, PhD

      Affiliations

    • Aetna Inc Hartford, CT
    • ,
  • Robert J. Glynn, ScD, PhD

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • ,
  • Mark Rubino, MHA, RPh

      Affiliations

    • Aetna Inc Hartford, CT
    • ,
  • Sebastian Schneeweiss, MD, ScD

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • ,
  • Alan M. Brookhart, PhD

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • ,
  • Joaquim Fernandes, MS

      Affiliations

    • Aetna Inc Hartford, CT
    • ,
  • Susan Mathew, MPH

      Affiliations

    • Aetna Inc Hartford, CT
    • ,
  • Blake Christiansen, MS, RPh

      Affiliations

    • Aetna Inc Hartford, CT
    • ,
  • Elliott M. Antman, MD

      Affiliations

    • Division of Cardiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • ,
  • Jerry Avorn, MD

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
    • ,
  • William H. Shrank, MD, MSHS

      Affiliations

    • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Received 26 November 2007; accepted 12 March 2008. published online 09 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Trial Registration Number: NCT00566774.

 Funding information: This work was supported by a research grant from Aetna Inc to Brigham and Women's Hospital.

PII: S0002-8703(08)00231-7

doi:10.1016/j.ahj.2008.03.021

American Heart Journal
Volume 156, Issue 1 , Pages 31-36, July 2008

Article Tools